(Q43736429)
Statements
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy (English)
N Harbeck
U Alt
U Berger
A Krüger
C Thomssen
F Jänicke
H Höfler
R E Kates
1 September 2001